|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 7.600 USD | -0.65% |
|
+9.04% | +133.85% |
| 09-09 | UBS Adjusts Maravai Lifesciences Price Target to $8 From $2.50, Maintains Neutral Rating | MT |
| 08-20 | Top Midday Gainers | MT |
| Market Cap | 1.13B 994M 938M 855M 1.6B 109B 1.61B 11.23B 4.35B 55.44B 4.25B 4.16B 178B | P/E 2026 * |
-24.7x | P/E 2027 * | -32x |
|---|---|---|---|---|---|
| Enterprise Value | 1.23B 1.08B 1.02B 926M 1.73B 117B 1.75B 12.16B 4.71B 60.02B 4.6B 4.5B 193B | EV / Sales 2026 * |
5.79x | EV / Sales 2027 * | 5.28x |
| Free-Float |
45.46% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MRVI | Delayed | |
CBOE
| MRVI | Real-time | |
|
Tradegate
| MAR | Real-time | |
|
Börse Stuttgart
| MAR | Delayed | |
|
Deutsche Boerse AG
| MAR | Delayed |
Last Transcript: Maravai LifeSciences Holdings, Inc.
| 1 day | -0.65% | ||
| 1 week | +9.04% | ||
| Current month | -0.52% | ||
| 1 month | -14.61% | ||
| 3 months | +22.19% | ||
| 6 months | +145.95% | ||
| Current year | +133.85% |
| 1 week | 6.92 |  | 7.76 |
| 1 month | 6.48 | | 8.18 |
| Current year | 2.8 | | 9.42 |
| 1 year | 2.54 | | 9.42 |
| 3 years | 1.66 | | 11.56 |
| 5 years | 1.66 | | 49.95 |
| 10 years | 1.66 | | 63.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bernd Brust
CEO | Chief Executive Officer | 59 | 2025-06-07 |
| Director of Finance/CFO | 59 | 2025-06-29 | |
Elie Chaaya
COO | Chief Operating Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Cunningham
BRD | Director/Board Member | 50 | 2016-02-29 |
Susannah Gray
BRD | Director/Board Member | 65 | 2020-10-31 |
Gregory Lucier
BRD | Director/Board Member | 61 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/8/26 | Tax | Chief Executive Officer | -29,250 | 0.0196% | ||
| 8/31/26 | Tax | Chief Financial Officer | -5,465 | 0.0037% | ||
| 8/10/26 | Tax | Chief Executive Officer | -29,250 | 0.0198% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.65% | +9.04% | +169.50% | -16.85% | 1.13B | |
| +1.85% | +7.32% | +421.33% | +147.75% | 4.98B | |
| -0.47% | +2.87% | +122.62% | +429.32% | 4.7B | |
| -6.41% | +14.16% | +35.86% | +101.20% | 3.65B | |
| +3.76% | +18.30% | +326.52% | +765.22% | 3.29B | |
| +2.50% | +13.65% | -7.45% | -14.14% | 2.58B | |
| -4.59% | -8.24% | +48.11% | - | 1.72B | |
| -0.58% | +0.59% | +36.00% | +63.46% | 1.14B | |
| +5.08% | +8.18% | -21.14% | +142.84% | 629M | |
| -1.62% | +1.94% | -30.43% | -17.53% | 529M | |
| Average | -0.11% | +6.85% | +110.09% | +177.92% | 2.44B | |
| Weighted average by Cap. | -0.19% | +8.45% | +170.35% | +253.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 212M 186M 175M 160M 299M 20.28B 301M 2.1B 813M 10.36B 795M 777M 33.3B | 225M 198M 187M 170M 319M 21.61B 321M 2.24B 866M 11.04B 846M 828M 35.47B |
| Net income | -51.28M -44.99M -42.5M -38.73M -72.49M -4.91B -73.01M -509M -197M -2.51B -193M -188M -8.07B | -35.83M -31.44M -29.69M -27.06M -50.66M -3.43B -51.02M -355M -138M -1.75B -135M -132M -5.64B |
| Net Debt | 93.41M 81.97M 77.42M 70.55M 132M 8.95B 133M 926M 359M 4.57B 351M 343M 14.7B | 58.85M 51.64M 48.78M 44.45M 83.21M 5.64B 83.8M 584M 226M 2.88B 221M 216M 9.26B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-25 | US$7.600 | -0.65% | 1,930,865 |
| 26-09-24 | US$7.650 | +3.80% | 2,392,705 |
| 26-09-23 | US$7.370 | -1.21% | 1,549,775 |
| 26-09-22 | US$7.460 | +4.04% | 1,570,988 |
| 26-09-21 | US$7.170 | +2.87% | 2,300,323 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRVI Stock
Select your edition
All financial news and data tailored to specific country editions
